157 related articles for article (PubMed ID: 1693186)
41. Differential expression in Escherichia coli of the alpha and beta forms of heparin-binding acidic fibroblast growth factor-1: potential role of RNA secondary structure.
Forough R; Engleka K; Thompson JA; Jackson A; Imamura T; Maciag T
Biochim Biophys Acta; 1991 Nov; 1090(3):293-8. PubMed ID: 1720023
[TBL] [Abstract][Full Text] [Related]
42. Differential splicing of thymosin beta 4 mRNA.
Rudin CM; Engler P; Storb U
J Immunol; 1990 Jun; 144(12):4857-62. PubMed ID: 2351831
[TBL] [Abstract][Full Text] [Related]
43. Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor.
Brigstock DR; Steffen CL; Kim GY; Vegunta RK; Diehl JR; Harding PA
J Biol Chem; 1997 Aug; 272(32):20275-82. PubMed ID: 9242708
[TBL] [Abstract][Full Text] [Related]
44. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors.
Wu DQ; Kan MK; Sato GH; Okamoto T; Sato JD
J Biol Chem; 1991 Sep; 266(25):16778-85. PubMed ID: 1885605
[TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibodies against heparin-binding growth factor-1: neutralization of biological activity and recognition of specific amino acid sequence.
Myoken Y; Kan M; Chen J; McKeehan WL; Sato GH; Sato JD
Biochem Biophys Res Commun; 1993 Dec; 197(3):1450-7. PubMed ID: 7506543
[TBL] [Abstract][Full Text] [Related]
46. The bovine mimecan gene. Molecular cloning and characterization of two major RNA transcripts generated by alternative use of two splice acceptor sites in the third exon.
Tasheva ES; Funderburgh ML; McReynolds J; Funderburgh JL; Conrad GW
J Biol Chem; 1999 Jun; 274(26):18693-701. PubMed ID: 10373482
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat.
Rosengart TK; Kuperschmid JP; Maciag T; Clark RE
Circ Res; 1989 Feb; 64(2):227-34. PubMed ID: 2463884
[TBL] [Abstract][Full Text] [Related]
48. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence.
Imamura T; Engleka K; Zhan X; Tokita Y; Forough R; Roeder D; Jackson A; Maier JA; Hla T; Maciag T
Science; 1990 Sep; 249(4976):1567-70. PubMed ID: 1699274
[TBL] [Abstract][Full Text] [Related]
49. Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor.
Kurachi K; Davie EW; Strydom DJ; Riordan JF; Vallee BL
Biochemistry; 1985 Sep; 24(20):5494-9. PubMed ID: 2866795
[TBL] [Abstract][Full Text] [Related]
50. Cloning of two different 5' untranslated exons of bovine acidic fibroblast growth factor by the single strand ligation to single-stranded cDNA methodology.
Philippe JM; Renaud F; Desset S; Laurent M; Mallet J; Courtois Y; Edwards JB
Biochem Biophys Res Commun; 1992 Oct; 188(2):843-50. PubMed ID: 1280126
[TBL] [Abstract][Full Text] [Related]
51. Cloning of two novel forms of human acidic fibroblast growth factor (aFGF) mRNA.
Payson RA; Canatan H; Chotani MA; Wang WP; Harris SE; Myers RL; Chiu IM
Nucleic Acids Res; 1993 Feb; 21(3):489-95. PubMed ID: 7680120
[TBL] [Abstract][Full Text] [Related]
52. Multiple polyadenylation sites downstream from the human aFGF gene encoding acidic fibroblast growth factor.
Crumley GR; Howk R; Ravera MW; Jaye M
Gene; 1989 Dec; 85(2):489-97. PubMed ID: 2628180
[TBL] [Abstract][Full Text] [Related]
53. Structure of the rat insulin-like growth factor II transcriptional unit: heterogeneous transcripts are generated from two promoters by use of multiple polyadenylation sites and differential ribonucleic acid splicing.
Chiariotti L; Brown AL; Frunzio R; Clemmons DR; Rechler MM; Bruni CB
Mol Endocrinol; 1988 Nov; 2(11):1115-26. PubMed ID: 3221878
[TBL] [Abstract][Full Text] [Related]
54. The gene for human acidic fibroblast growth factor encodes two upstream exons alternatively spliced to the first coding exon.
Crumley G; Dionne CA; Jaye M
Biochem Biophys Res Commun; 1990 Aug; 171(1):7-13. PubMed ID: 2393407
[TBL] [Abstract][Full Text] [Related]
55. Internalization and degradation of heparin binding growth factor-I by endothelial cells.
Friesel R; Maciag T
Biochem Biophys Res Commun; 1988 Mar; 151(3):957-64. PubMed ID: 2451523
[TBL] [Abstract][Full Text] [Related]
56. Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1: lack of correlation with growth factor binding.
Belford DA; Hendry IA; Parish CR
Biochemistry; 1992 Jul; 31(28):6498-503. PubMed ID: 1378755
[TBL] [Abstract][Full Text] [Related]
57. Isolation and characterization of different molecular and chromatographic forms of heparin-binding growth factor 1 from bovine brain.
McKeehan WL; Crabb JW
Anal Biochem; 1987 Aug; 164(2):563-9. PubMed ID: 2445228
[TBL] [Abstract][Full Text] [Related]
58. cDNA cloning of porcine transforming growth factor-beta 1 mRNAs. Evidence for alternate splicing and polyadenylation.
Kondaiah P; Van Obberghen-Schilling E; Ludwig RL; Dhar R; Sporn MB; Roberts AB
J Biol Chem; 1988 Dec; 263(34):18313-7. PubMed ID: 2461367
[TBL] [Abstract][Full Text] [Related]
59. A rat brain-derived neurotrophic factor-encoding gene generates multiple transcripts through alternative use of 5' exons and polyadenylation sites.
Ohara O; Gahara Y; Teraoka H; Kitamura T
Gene; 1992 Nov; 121(2):383-6. PubMed ID: 1446835
[TBL] [Abstract][Full Text] [Related]
60. Phorbol ester reduces number of heparin-binding growth-factor receptors in human adult endothelial cells.
Hoshi H; Kan M; Mioh H; Chen JK; McKeehan WL
FASEB J; 1988 Sep; 2(12):2797-800. PubMed ID: 2457532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
